skip to content
CMS Buy Now
Detailed Quote
5i Report
Rating
B+

Review of Cineplex Inc

OCT 16, 2018 - Cinema operator facing several headwinds including slow growth. Still a well-run company with cheap valuation and near monopoly. Rating downgraded a notch to 'B+'.

Download Report
Company Profile
Interactive Chart
Key Ratios
Top Banner 5i Free Trial
Earnings
Analyst Recommendations
5i Recent Questions

Q: I am a long term holder of CGX (retired, diversified portfolio, like the monthly dividend). I have caught the falling knife a few times on this one, as I expect a number of others have as well. The diversification story is supposedly a 2019-2020 event, but until that kicks in, we are for the most part at the mercy of the proverbial "movie slate". Now that the current new movies have hit the theatres over the Christmas period, I am wondering whether this new batch (Aquaman, Mary Poppins, etc) can be considered a strong slate or not? How do the box office numbers look and what do you think the impact might be on the next quarter or two for CGX? At a 7+% dividend, I am ok with that plus a little bit of rebound growth. I have some further top-up money set aside that could be deployed towards CGX and elsewhere. Your thoughts? Thanks...Steve

Read Answer Asked by Stephen on December 27, 2018
Insiders
5i Free Trial 300x250
Share Information
News and Media